Summary. Antibody to at least one type of streptococcal opacity factor (OF) was present in 39.0% of 235 selected subjects and, in 4743% of these, to more than one type. Only 21.6% of children less than 4 years old had antibody to OF; these were to one type in 62.5% or to more than one in 37.5%. In the study group as a whole, the commonest antibodies were those to OF from M-serotype 25 followed, in descending order, by serotypes 4,22,2,9,48,49,28,61 and 75. Patients with rheumatic fever or rheumatic heart disease most often had antibodies to OF from M-types 25, 22, 4 and 9, whereas in patients with acute glomerulonephritis, antibodies to OF from M-types 48,49 and 61 were commonest. The limitations of the OFinhibition test as an epidemiological marker for prevalent M-types of group A streptococci are discussed.
Introduction
The production of opacity factor (OF), a lipoproteinase, by certain serotypes of /I-haemolytic streptococci of Lancefield's group A is well documented. '* OF is serologically specific3 and corresponds exactly with the M-type of the streptococcus that produces i t 4 Antibodies to OF persist in human sera for 4-12 years.2 Although only 27 of the 71 M-serotypes' currently known produce OF,2 the consistent production of OF, its type specificity and its close association with M-antigen, and especially the fact that 4540% of all isolates of group A streptococci produce OF,6y suggest that identification of antibody to OF could be used to reflect the prevalence of streptococcal M-types in a population.8* In the present study, the prevalence of OF antibody in a selected population has been examined, and by extension, exposure to specific OF-positive M-serotypes has been determined.
Materials and methods

Subjects
From 1986 to 1989, sera were collected and examined from 235 subjects aged from one to 30 years (mean 15.5 years). All were attending the Kalawati Saran Children's Hospital, the Smt. Sucheta Kriplani Hospital, the All India Heart Foundation or the All India Institute of Medical Sciences, New Delhi.
Thirty sera were collected from eight male and 22 female patients, mainly outpatients who were suffering from recurrent sore throat with a positive throat culture for a P-haemolytic group A streptococcus or had supportive evidence of group A streptococcal infection in the form of an elevated titre of AS0 or anti-DNAase B or both. Eighty-five sera were collected from 58 male and 27 female patients with rheumatic fever (RF) or rheumatic heart disease (RHD) diagnosed on the basis of modified Jones' Criteria;" they were receiving 1 a2 mega-units of benzathine penicillin every 3 weeks as secondary prophylaxis. Fifty sera were collected from 29 male and 21 female patients with clincially confirmed acute glomerulonephritis' (AGN) with skin or throat culture positive for the group A streptococcus or supporting evidence of group A streptococcal infection in the form of an elevated titre of AS0 or anti-DNAase B or both. Control sera were collected from 70 children and adults, matched for age and sex, who lacked bacteriological or serological evidence or recent group A streptococcal infection.
Streptococcal strains
Twenty-two OF-producing strains of group A streptococci (table I) and a non-producing control strain of Lancefield's group C (Chestle Prague No. 41/ 59) were obtained from (the late) Dr J. Rotta, Director, 
Test for OF
All 22 strains were tested for OF production after growth overnight at 30°C in 20ml of Todd-Hewitt Broth (Difco Laboratories, Detroit, Michigan, USA) to which neopeptone 1% w/v had been added. After centrifugation at 3000 rpm for 15 min, each supernate was tested for the serum opacity reaction (SOR) by an agar slide method' with pig serum as substrate. Briefly, pig serum (1 ml) adjusted to pH 6.0 was mixed with 1 ml of molten Noble Agar (Difco) 2% w/v in distilled water at 50°C and the mixture was poured evenly over a 5 x5-cm glass slide, allowed to solidify, and thereafter dried for 10 min at 37°C. Culture supernates were spotted on to the slide with a 2-mm loop and the slides were placed in a moist chamber for overnight incubation at 37°C.
A positive reaction was indicated by the development of a zone of opacity. Supernates containing OF were preserved at 4°C after sodium merthiolate was added to a final concentration of 1 : 5000 w : v. These preparations could be used thereafter for up to 4 weeks to detect anti-OF antibodies in human sera. One standard strain of group C was used as a negative control throughout the study.
Determination of anti-OF antibodies in human sera
To 1 ml of pig serum, 0.3 ml of OF preparation and 1 ml of molten Noble Agar 2% at 50°C were added. The mixture was poured on to a 5 x 5-cm glass slide. One such slide was prepared with each of the 22 OF preparations. The slides were dried for 10 min at 37°C before each of the 165 test and 70 control sera was spotted with a 2mm loop onto the surface of slides prepared with each OF. Sixteen sera could be tested conveniently on one slide. The slides were incubated in a moist chamber overnight at 37°C. A clear area in the opaque background was taken to indicate anti-OF anti body. '
Results
Of 235 sera tested, 92 (39.0%) contained antibodies either to a single OF type (52.2%) or to multiple OF types (47.8%). Of 37 samples from children aged 1-4 years, including three with RF/RHD, seven with AGN, one with pharyngitis and 26 normal controls, 8 (214%) contained antibodies to OF. None of the sera from patients with RF/RHD or pharyngitis contained OF antibodies whereas four of seven sera from patients with AGN did, in one case against a single OF type and in three against multiple OF types. In 26 normal control children, aged 1-4 years, four had OF antibodies against single M-serotypes (table 11) .
Serum from 49.0% of subjects more than 4 years old contained antibody to single or multiple OF types. Sera from patients with pharyngitis were most likely to contain antibody (53.3%) followed by sera from patients with RF/RHD (44.773, with AGN (38.0%) and from normal subjects (27.0%). Antibodies to more than one OF type were more likely in patients with RF/RHD (55.373, than in patients with pharyngitis (437%) or AGN (42.0%) or in healthy subjects (4200%). More sera from patients with RF/RHD contained antibody to two or more OF types (5503%) than to a single serotype (44.7%). These antibodies to OF in patients with RF/RHD sera were to OF from M-types 25 (16 cases), 22 (13), 4 (10) and 9 (9); the serum of five of these patients each contained antibodies to four different M-serotypes (table 111) .
In patients with AGN the most prevalent antibodies were those to OF from M-types 48 (8 cases), 59 (5) and 61 (4). In this group, most of the sera (57.9%) contained antibody to OF from a single serotype, most commonly M-type 48 or 49. Eight serum samples had antibody to OF from more than one M-serotype. Antibodies to OF from M-serotypes most often seen in RF/RHD-25, 22 and &were also present in sera from patients with AGN, though less often. However, antibodies to OF from M-type 9, seen in nine patients with RF/ RHD, were not found in patients with AGN. Similarly, antibodies to OF from M-type 49 or 61 (frequent in patients with AGN) were not found in patients with RF/RHD (table 111) .
Sera from patients with pharyngitis most often contained antibodies to OF from M-type 2 (8 cases). However, antibodies to OF from types 25,22,4 and 9 (often present in the serum of patients with RF/RHD) were present also in the sera of patients with pharyngitis (table IV) . In normal subjects too, antibodies to OF from M-serotypes 25,4 and 49 were frequent. The serum of healthy subjects more often contained antibody to OF from a single M-serotype (57.9%) than from multiple types (42.0%). None of the sera tested contained antibodies to OF from M-types 60 or 62. Within the population studied, antibodies to OF from M-type 25 were commonest (25), followed by types 4 (19), 22 (18), 2 (1 1), 9 and 48 (10 each), 49 (8) and 28,61,75 (three each) (table V). 
Discussion
It has been suggested that inhibition of OF by specific antibody might allow evaluation of a population's previous exposure to specific OF-positive Mserotypes of group A streptococci.2 However, although antibodies to OF in general parallel M-antibodies, so that a complex bactericidal test can be replaced by simpler enzyme neutralisation, the epidemiological value of studies based on detection of antibody to OF is limited as only 27 M-serotypes of group A streptococci are currently recognised as OF producers.2 However, in practice 4540% of all clinical isolates of group A streptococci produce OF6y7 so that, by studying antibodies to OF in human sera, it is possible to judge indirectly but usefully the prevalence of infection by different serotypes of streptococci in different populations. The infrequent isolation' and poor M-typability of at the time of the development of streptococcal sequelae are the two major constraints in projecting with certainty the responsible and prevalent streptococcal serotypes in a population.
In the present study antibodies to OF were present in 39.0% of the sera tested. Of these, 47.8% contained antibodies to more than one OF type, suggesting repeated streptococcal infection but with different OF types. Only 21.6% of children aged up to 4 years had antibodies to OF. In three patients, all with AGN, antibody to more than one OF type was present. The other children, both those who had streptococcal infection and healthy controls, had antibody to a single OF type. It has been reported that the incidence of RF varies with age, the peak both for first attacks and recurrences being between 5 and 15 years. ' However, in developing countries, onset at between 3 and 5 years of age is not ~nusual,'~-~' and serological response to streptococcal infection in children less than 5 years old is generally poor, irrespective of the M-serotype involved. * Repeated streptococcal infections are common in patients who develop streptococcal sequelae, especially RF/RHD. ' In the present study most patients with RF/RHD (55.3%) had antibodies to more than one OF type. Reviewing outbreaks of RF, St~llerman'~ found that a limited number of serotypes were involved (M-types 5,18, 19, 24) and that none of these produced OF. However, M-420 and M-1 1 14* 21 OF-positive serotypes have been reported to be associated with RF. The definition of rheumatogenic strains remains unclear.
Antibodies to OF of M-serotypes 25, 22, 4 and 9 were commoner in RF/RHD cases but it is doubtful if such types cause reactivation of the disease : antibodies to OF of M-serotypes 25 and 4 were also quite common in normal subjects.
The prevalence of higher M-types22 (49 and above) in patients with AGN has been reported; the finding in the present study of antibodies to OF of M-serotypes 48, 49, 61 in patients with AGN agrees with this. Serotype M-49 has been implicated in AGN in widely differing locations23 but is more often associated with pyoderma than with pharyngitis.
Antibodies to OF have been reported to persist for as long as M-type specific antibodies.2y24 Study of their type-specificity indirectly but usefully indicates the serotypes of streptococci prevalent in different populations.
